Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Clinical trial NCT01983761 · UNKNOWN

Trial details

NCT number: NCT01983761
Sponsor: Targazyme, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Blood And Marrow Transplantation Leukemia Lymphoma Transplantation Infection Myelodysplastic Syndrome (MDS)Non-Hodgkin's Lymphoma (NHL)Hodgkin's Lymphoma

Start date: 2013-11-01
Primary completion: 2014-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.